Chijian Zuo
VP CureMed Biopharma
Ph.D. of The University of Freiburg (Germany), Chijian has 10 years’ experience in pharmaceutical industry. Their focus is on circRNA based therapeutics development in the past 6 years.
Seminars
Tuesday 21st July 2026
CircRNA-Based Potential Therapeutics for Tumor Therapy & Autoimmune Diseases
2:30 pm
- Clean-PIE circRNA platform of CureMed
- cmRNA1210: CircRNA based IL-12 for solid tumor
- CircRNA based in vivo TCE/CAR-T
